IRVING,
Texas, April 13, 2022 /PRNewswire/ --Darling
Ingredients Inc. (NYSE: DAR) today announced that it's health
brand Rousselot®, the global leader of collagen-based
solutions1, launched GMP grade GelMA. X-Pure®
GelMA is the first gelatin methacryloyl, or GelMA, on the market to
be produced under GMP conditions2.
The production of X-Pure GelMA under GMP conditions is a major
step forward for companies that require GelMA for clinical use and
in body medical applications. Up until now, research grade GelMA
was the only available option. The GMP process ensures that
Rousselot X-pure GelMAs are consistently produced and controlled
according to strict quality standards, including consistent
chemical modification and purification methods.
Because X-Pure GelMA has been designed for use throughout the
entire product life cycle, from early-stage research through to
clinical trials and marketed products, it supports a faster route
to market by minimizing the risk of having to revalidate data.
Batch-to-batch consistency and quality is guaranteed at any
scale.
"We are proud to be the first in the market to offer GelMA
produced under GMP," says Kathleen
Jacobs (PhD), Regulatory Affairs Director at Rousselot
Biomedical. "In less than two years, we developed a research grade
as well as an X-Pure GelMA produced under suitable GMP. This marks
our commitment to support customer needs. By creating reliable
gelatin products with optimal properties and quality, we are
helping customers to achieve success."
Research grade X-Pure GelMA was launched in June 2020 as a premium alternative to standard
research grade GelMAs. It offers ultra-low impurity levels
(including endotoxins, methacrylic acid and DNA), batch-to-batch
consistency and tunable mechanical properties. It is ideal for a
wide range of in vitro and in vivo research and
development applications, particularly regenerative medicine
applications such as tissue engineering, 3D bioprinting and 3D cell
culture.
The product launch is being announced at the 6th
edition of Rousselot's Innovation Days, which are taking place on
13th and 14th April
2022 in Ghent, Belgium.
This major event for Rousselot takes place every two years,
enabling our customers and partners to gain exclusive insights into
the latest research in collagen-based innovations.
To find out more about Rousselot Biomedical and X-Pure GelMA,
please visit our website: www.rousselot.com/biomedical
References:
1. Global Gelatin Market Insights Forecast to 2026 Calibre
Research, 2020
2. IPEC PQG Good Manufacturing Guide for pharmaceutical excipients
(2017)
About Darling
Darling Ingredients Inc. (NYSE: DAR) is
a world leading producer of organic ingredients, generating a wide
array of sustainable protein and fat products while being one of
the largest producers of renewable clean energy. With operations on
five continents, Darling collects waste streams from the agri-food
industry, repurposing into specialty ingredients, such as
hydrolyzed collagen, edible and feed-grade fats, animal proteins
and meals, plasma, pet food ingredients, fuel feedstocks, and green
bioenergy. Darling Ingredients named one of the 50 Sustainability
and Climate Leaders in 2021, to learn more Darling Ingredients: The
greenest Company on the planet - 50 Sustainability & Climate
Leaders (50climateleaders.com). The Company sells its ingredients
around the globe and works to strengthen our promise for a better
tomorrow, creating product applications for health, nutrients and
bioenergy while optimizing our services to the food chain. Darling
is a 50% joint venture partner in Diamond
Green Diesel (DGD), North
America's largest renewable diesel manufacturer, which
products reduce Greenhouse Gas (GHG) emissions by up to 85%
compared to fossil fuels. For additional information, visit the
Company's website at http://www.darlingii.com.
Rousselot® Biomedical
As the most recent strategic segment within Rousselot, we have
drawn upon Rousselot's 130+ years of worldwide expertise and proven
track record of pharmaceutical gelatins and collagens to develop
innovative ranges of purified, modified and non-modified gelatins
and collagens for biomedical applications. Offering unique
advantages to assure performance, quality and safety from bench to
clinic, Rousselot® X-Pure® and
Rousselot® Quali-Pure™ provide consistent quality
and are backed by strong scientific data and on-going research.
Rousselot Biomedical is committed to support end-to-end
partnerships to help "Advancing medical
science". https://www.rousselot.com/biomedical
For further information, please
contact:
Rousselot
Caroline Brochard-Garnier
Director of Communications & PR, Rousselot
E: caroline.brochard-garnier@rousselot.com
Sciad Communications
Maria Patey / Sophie Protheroe
E: rousselot@sciad.com
T: +44 (0)20 3405 7892
Suann Guthrie
VP, Investor Relations, Sustainability & Communications
(469) 214-8202
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rousselot-biomedical-darling-ingredients-brand-announces-the-worlds-first-gelma-produced-under-gmp-301525367.html
SOURCE Darling Ingredients Inc.